Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  PerkinElmer, Inc.    PKI

Delayed Quote. Delayed  - 07/25 10:02:01 pm
68.23 USD   -1.64%
07/24 PERKINELMER : Board Declares Quarterly Dividend
07/19 INTERVIEW : PerkinElmer's Q-SIGHT LCMS/MS
07/19 PERKINELMER, IN : ex-dividend day
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

PerkinElmer, Inc. : PerkinElmer Board Declares Quarterly Dividend

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/25/2013 | 10:10pm CEST

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on January 25, 2013. This dividend is payable on May 10, 2013, to all shareholders of record at the close of business on April 19, 2013.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $1.9 billion in 2011, has about 7,400 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Investor Relations:
PerkinElmer, Inc.
Tommy J. Thomas, 781-663-5889
tommy.thomas@perkinelmer.com
or
Media Contact:
PerkinElmer, Inc.
Stephanie R. Wasco, 781-663-5701
stephanie.wasco@perkinelmer.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PERKINELMER, INC.
07/24 PERKINELMER : Board Declares Quarterly Dividend
07/19 INTERVIEW : PerkinElmer's Q-SIGHT LCMS/MS
07/19 PERKINELMER, INC. : ex-dividend day
07/10 PERKINELMER : to Hold Earnings Call on Thursday, August 3, 2017
07/06 PERKINELMER : Groundbreaking Multi-Center Clinical Trial Confirms Low-Dose Aspir..
07/03 PERKINELMER : Procurement of supplies and equipment service PerkinElmer
07/03 PERKINELMER : Combine Solicitation - Automatic Gamma Counter
07/01 PERKINELMER : Hogan Lovells Advises PerkinElmer, Inc. on Acquisition of EUROIMMU..
06/29 PERKINELMER : Global Biochip Products Market 2017- Illumina, Thermo Fisher Scien..
06/28 PERKINELMER : Combine Solicitation - Perkin Elmer Equipment Maintenance Service
More news
News from SeekingAlpha
07/24 PerkinElmer declares $0.07 dividend
06/22 PerkinElmer - EUROIMMUN Looks Like A Very Decent Addition
06/21 PerkinElmer Ups Diagnostics Game With Euroimmun Buy
06/19 PerkinElmer To Acquire EUROIMMUN For Complementary Products And Distribution
06/19 PerkinElmer takes out EUROIMMUN for $1.3B
Financials ($)
Sales 2017 2 212 M
EBIT 2017 421 M
Net income 2017 255 M
Debt 2017 237 M
Yield 2017 0,40%
P/E ratio 2017 30,54
P/E ratio 2018 27,04
EV / Sales 2017 3,56x
EV / Sales 2018 3,41x
Capitalization 7 633 M
Chart PERKINELMER, INC.
Duration : Period :
PerkinElmer, Inc. Technical Analysis Chart | PKI | US7140461093 | 4-Traders
Technical analysis trends PERKINELMER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 67,8 $
Spread / Average Target -2,3%
EPS Revisions
Managers
NameTitle
Robert F. Friel Chairman, President & Chief Executive Officer
Frank Anders Wilson Chief Financial Officer & Senior Vice President
Nicholas A. Lopardo Independent Director
Alexis Platon Michas Lead Independent Director
Patrick J. Sullivan Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PERKINELMER, INC.33.02%7 633
THERMO FISHER SCIENTIFIC INC.29.10%71 265
DANAHER6.69%57 680
BOSTON SCIENTIFIC CORPORATION27.69%37 823
ROYAL PHILIPS11.14%35 345
INTUITIVE SURGICAL46.25%35 263